Vogelxo (testosterone) NDC 0245-0871

NDC codes

FDA NDC Directory

Product NDC (as listed)0245-0871Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00245-0871Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0245-0871-05	00245087105	30 TUBE in 1 CARTON (0245-0871-05) / 5 g in 1 TUBE (0245-0871-65)Marketed from Jun 9, 2014
0245-0871-35	00245087135	30 PACKET in 1 CARTON (0245-0871-35) / 5 g in 1 PACKET (0245-0871-89)Marketed from Jun 9, 2014

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Vogelxo
Generic name (nonproprietary): testosterone
Active ingredients: Testosterone — 50 mg/5g
Dosage form: Gel
Route: Topical
Labeler: Upsher-Smith Laboratories, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 204399
Marketing start: Jun 9, 2014
Listing expires: Dec 31, 2026
DEA schedule: CIII
Other FDA classes: Androgen Receptor Agonists (Mechanism)Androstanes (Chemical structure)
Identifiers: Product ID 0245-0871_39e7ddfb-c092-4cb7-e063-6394a90a1d54SPL ID 39e7ddfb-c092-4cb7-e063-6394a90a1d54SPL set ID 2dd150f6-cdfd-4d51-8888-12b288f26262RxCUI 1596780, 1596785, 1597129, 1597134UNII 3XMK78S47O
Pharmacologic class: Androgen

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400245087105 followed by a unit qualifier and the quantity

Package 00245-0871-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 14, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Vogelxo is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone levels and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic inj…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 204399

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 204399
Product	Strength	Form · route	Labeler	Product NDC
Vogelxotestosterone	Testosterone 12.5 mg/1	Gel, MeteredTopical	Upsher-Smith Laboratories, LLC	0245-0872
Testosterone	Testosterone 50 mg/5g	GelTopical	Upsher-Smith Laboratories, LLC	0832-1120
Testosterone	Testosterone 12.5 mg/1	Gel, MeteredTopical	Upsher-Smith Laboratories, LLC	0832-1121